Development of a prognostic prediction model for non-smoking lung adenocarcinoma based on pathological information and laboratory hematologic indicators: a multicenter study
- Run Xiang 1,2, Peihong Hu 2, Xiaoxiong Xiao 3,4, Wen Li 5,6, Xiaoqing Liao 7, Jun Li 8, Wen Zhu 1, Xiaoqin Liu 2, Qiang Li 2
- Run Xiang 1,2, Peihong Hu 2, Xiaoxiong Xiao 3,4
- 1State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
- 2Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
- 3Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- 4Xiangya Lung Cancer Center, Xiangya Hospital, Central South University, National Clinical Research Center for Geriatric Disorders, Changsha, China.
- 5Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- 6Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- 7Department of Thoracic Surgery, Dazhu County People's Hospital, Dazhou, Sichuan, China.
- 8Department of Thoracic Surgery, Ziyang Yanjiang People's Hospital, Ziyang, Sichuan, China.
- 0State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new prognostic model accurately predicts survival in non-smoking lung adenocarcinoma patients using tumor stage, size, and simple blood markers. This model aids personalized treatment decisions for lung cancer patients.
Area Of Science
- Oncology
- Medical Diagnostics
- Biostatistics
Background
- Lung adenocarcinoma is a leading cause of cancer death.
- Accurate prognostic models are crucial for non-smoking patients.
- Existing models may not fully integrate hematologic indicators.
Purpose Of The Study
- To develop a practical prognostic model for non-smoking lung adenocarcinoma patients.
- To combine pathological information with hematologic indicators for survival prediction.
- To establish a nomogram for evaluating prognostic impact.
Main Methods
- Retrospective analysis of 1,172 non-smoking lung adenocarcinoma patients.
- Cox univariate and multivariate analyses to identify significant variables.
- Construction of a Cox proportional hazards model and a nomogram.
Main Results
- Multivariate analysis identified tumor TNM stage, size, WBC count, neutrophil%, lymphocyte%, and hemoglobin as significant predictors.
- The model demonstrated strong predictive performance with C-indices of 0.811 (training), 0.786 (test), and 0.810 (validation).
- AUC values for 3- and 5-year overall survival were consistently high across datasets, indicating effective outcome discrimination.
Conclusions
- A prognostic model integrating tumor characteristics and hematologic markers effectively predicts survival in non-smoking lung adenocarcinoma.
- The model's indicators are readily available and require no conversion, simplifying clinical application.
- This provides a valuable tool for personalized diagnosis and treatment strategies in clinical practice.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

